A recent report published by Infinium Global Research on epilepsy drug market provides in-depth analysis of segments and sub-segments in the global as well as regional epilepsy drug market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional epilepsy drug market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global epilepsy drug market. According to the report, the global epilepsy drug market is projected to grow at a CAGR of 7.1% over the forecast period of 2019-2025.
Epilepsy is a neurological disorder in which brain activity becomes abnormal, causing seizures or periods of unusual behavior, sensations, and sometimes loss of awareness. It occurs in both sexes, at all ages, particularly in childhood and an increase in aging populations. Moreover, the most common type of epilepsy is idiopathic epilepsy and has no identifiable cause. This brain disorder is usually treated by medication and in some cases by implantable devices, surgery, and dietary changes.
Growing prevalence’s of neurological disorders, growth in roadside accidents and rising occurrences of epilepsy across the globe are some factors driving the growth of epilepsy drug market. As per the World Health Organization, it is estimated that around 50 million patients are living with epilepsy and about 2.4 million people are diagnosed with epilepsy each year. Furthermore, anti-epilepsy drugs Epidiolex approvals for pediatric epilepsies is another factor help in the growth of the epilepsy drug market. Additionally, growing awareness about epilepsy among the people, increasing government funding and drugs reimbursement options are further expected to fuel the market growth. However, less awareness regarding epilepsy drug in middle-income economies is likely to restraints the growth of epilepsy drug market. Going further, growing R&D investment and number of manufacturers are more focusing on developing the greatly effective and safe medicines to control seizures in patients suffering from epilepsy disorder are creating growth opportunities for the growth of epilepsy drug market.
Geographically, North America is expected to hold maximum share in the epilepsy drug market. The factors such as increased investment in the R&D, presence of favorable government initiatives and new product development are responsible for the growth of the market in the North America region. According to data released by CDC’s, the number of U.S. children and adults with epilepsy are growing, with at least 3.4 million people living with epilepsy disorder. Epilepsy is more common in developing countries than in developed ones. Moreover, Asia Pacific is anticipated to witness the highest growth rate during the forecast period. The growth of this region is attributed due to growing awareness regarding epilepsy drug and increasing incidences of brain injuries.
The report on global epilepsy drug market covers segments such as product type. On the basis of product type, the sub-markets include first-generation drugs, second-generation drugs, and third generation drugs.
The report provides profiles of the companies in the market such as Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals, Inc., GlaxoSmithKline plc, Abbott Laboratories, Sanofi S.A., Novartis International AG, Eisai Co., Ltd., Pfizer Inc., UCB S.A., and Johnson & Johnson.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of epilepsy drug market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter